|Articles|June 10, 2015
Bristol-Myers Squibb Commits to SCRS
Author(s)Company Press Release
The Society for Clinical Research Sites (SCRS), a global trade organization dedicated to the interests of clinical research sites, announced a two-year partnership with Bristol-Myers Squibb.
Advertisement
The Society for Clinical Research Sites (SCRS), a global trade organization dedicated to the interests of clinical research sites, announced a two-year partnership with Bristol-Myers Squibb, a leading global biopharmaceutical company. Bristol-Myers Squibb will participate as a Global Impact Partner (GIP), a relationship indicative of Bristol-Myers Squibb’s dedication to promoting greater site sustainability across the global clinical research landscape. Bristol-Myers Squibb will also host a Site Advocacy Group . As a GIP, Bristol-Myers Squibb will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025
Advertisement
Advertisement